The present invention provides a novel class of monoclonal antibodies whi ch bind ErbB3 receptor and inhibits various ErbB3 functions. For example, th e antibodies described herein are capable of binding to ErbB3 and inhibiting EGF-like ligand mediated phosphorylation of the receptor.
